Firm Overview

Systematica Investments launched in January 2015 after a decade of experience within BlueCrest Capital Management, to focus on rigorously applying science and technology to the investment process. The firm was founded by Leda Braga and manages assets across a number of futures, equity and OTC based strategies. The philosophy of the firm is one of innovation, excellence in research and a commitment to fostering strong alignment with investors. Systematica Investments has a global presence with offices in Jersey, Geneva, London, New York and Singapore.

Our MissionTo create wealth by applying science and technology
  • Excellence

  • Innovation

  • Team Work

  • Pride

  • Fun

Team Culture & Investment Philosophy

  • The pursuit of excellence permeates all of Systematica’s activities
  • Collaborative working environment within and across all functional teams
  • Rigorous review by peers throughout the research and development cycle
  • We aim to be systematic investors and avoid intervening with the model
 - our interaction with the model is via the research process
  • Significant investment in technology 
– our trend following strategy is currently running on the third generation of our proprietary trading platform
  • All aspects of the investment process and platform are subject to continuous research 
and improvement

Management Team

  • Leda Braga

    CEO

    Former President and Head of Systematic Trading, BlueCrest. Leda joined BlueCrest from Cygnifi Derivatives Services (a J.P. Morgan spin-off) in October 2001. At Cygnifi she formed part of the management team and was head of its Valuation Service. Prior to Cygnifi, Leda spent nearly seven years at J.P. Morgan as a Quantitative Analyst in the derivatives research team. Her past experience includes modelling of interest rate exotics, FX/interest rate hybrid instruments and equity derivatives. She holds a PhD in Engineering from Imperial College London, where she worked as a lecturer and led research projects for over three years prior to joining J.P. Morgan.

  • Paul Rouse

    Chief Financial Officer / Chief Operating Officer

    Paul joined Systematica on launch in January 2015 as the Chief Financial Officer for the group and one of the two Jersey resident directors of the new investment manager, Systematica Investments Limited. In the 2.5 years as CFO Paul was responsible for building out the corporate finance and tax teams of Systematica, as well as heading up other key support teams such as Human Resources, Fund Accounting and the Client Service functions. Prior to joining Systematica, Paul served as Head of Product Control at BlueCrest managing teams in London, New York and Singapore. Paul joined BlueCrest in 2006 and for over 8.5 years covered all functional areas within the BlueCrest Product Control function. Previously, Paul was a Product Control manager at Goldman Sachs for 3 years focussing on equity derivatives trading. Paul trained as a Chartered Accountant at Ernst and Young within their Corporate Tax business, qualifying as an ACA in January 2003. He holds a BSc (Hons) in Marine Biology from Newcastle University.

  • David Kitson

    Chief Investment Officer

    Former Product Manager, BlueCrest. David joined BlueCrest in January 2011. Prior to BlueCrest, David was a Managing Director at J.P. Morgan where he worked from 1992 to 2010. He joined J.P. Morgan’s Quantitative Research Department after completing his PhD. David held many trading and management positions during his tenure at J.P. Morgan including: Head Trader Foreign Exchange Options, Head of Energy and Head Trader Fixed Income Hybrids. In 2007 he moved from trading management to focus his efforts solely on proprietary trading. David holds a PhD in Theoretical Physics from Manchester University.

  • Jean-Pierre Selvatico

    Head of Trading and Counterparty Management

    Former Head of Hedge Funds at Pictet Alternative Advisors, Jean-Pierre Selvatico joined Systematica in January 2017 as Head of Trading and Counterparty Management. Jean-Pierre worked for Pictet Alternative Advisors for 7 years where he acted as CIO of the hedge fund division, responsible for selecting and investing in external hedge funds across all strategies. Prior to joining Pictet, Jean-Pierre was a managing director at Barclays Capital in London in charge of the European interest rate option desk. He started his career in 1993 at JP Morgan London as a quantitative researcher and then moved to the interest rate swaps market-making desk. From 1997 to 2000 he managed the Dollar option desk for JP Morgan in New-York. Prior to joining Barclays Capital in 2004, he worked at Credit Suisse First Boston in London from 2002 to 2004.Jean-Pierre graduated from Ecole Polytechnique in Paris and later from Ecole Nationale de la Statistique et de l'Administration Economique (ENSAE).

  • Pawel Lewicki

    Head of Research

    Former Head of Systematic Research, BlueCrest. Pawel joined BlueCrest in January 2010 from Barclays Capital where, as a Managing Director, he acted as Global Head of Quantitative Analytics for three years. Prior to that, Pawel was a Managing Director at J.P. Morgan, where he worked for 12 years in the Derivatives Research and Strategy Group. Before starting his career in finance, Pawel led research work in statistical signal processing for Schlumberger in the US. Pawel has a PhD in Applied Mathematics from New York University's Courant Institute, with a specialisation in probability theory and random media. He holds a US patent in data analysis methods.

  • Ben Dixon

    General Counsel

    Former Legal Counsel, BlueCrest. Before joining Systematica, Ben previously worked for BlueCrest Capital for 9 years as Legal Counsel. He joined BlueCrest in 2005 from McDermott, Will & Emery, where he was an Associate Solicitor in the corporate department. He qualified as a solicitor in September 2003 with Allen & Overy in London, where he worked in the corporate and mergers & acquisitions department. Ben graduated from Queens' College, Cambridge University in 2000 and holds a BA (Hons) Law/MA (Cantab) Law. He undertook his LPC at Nottingham Law School in 2001.

  • Declan Ryan

    Head of Investor Relations

    Former Co-Head of Investor Relations North America, BlueCrest. Prior to joining BlueCrest, Declan was an Executive Director at UBS where he served as Head of Investor Relations in North America for UBS O’Connor, a multi-strategy hedge fund group. Before UBS Declan was a Vice President at JPMorgan Alternative Asset Management where he was responsible for business development and client relations. Declan is a CFA Charterholder and holds a Bachelor of Business and Law from University College Dublin (1995).

Investment Team

The investment team is organised functionally across three lines; Research, Technology and Trading with the Product Management team providing strategic oversight, coordination and development direction.